John Klimowich, Senior Executive Vice President and Chief Risk Officer of Columbia Financial, Inc./MD/ (NASDAQ:CLBK), filed a Form 4 on August 11, 2026, disclosing a non-discretionary acquisition of phantom stock on August 7, 2026, through the Columbia Bank Stock Based Deferral Plan.
Key Highlights
- Transaction date: August 7, 2026; 63.1568 shares of common stock acquired (code A) at $10.84 per share via the Columbia Bank Stock Based Deferral Plan, on a non-discretionary basis by the plan trustee.
- Deferral plan balance: Following the transaction, Klimowich held 20,464.6506 shares indirectly through the Stock-Based Deferral Plan.
- Direct holdings: 145,056 shares of common stock held directly.
- Additional indirect holdings: 67,686 shares via 401(k), 16,779 via SERP, 19,117 via ESOP, 9,269 via SIM, 24,135 via Stock Award III, 25,790 via Stock Award IV, and 26,193 via Stock Award V.
- Stock options: Klimowich holds options to purchase a total of 549,234 shares across five grants with exercise prices ranging from $7.10 to $8.31 per share.
Klimowich's Beneficial Ownership and Plan Holdings at Columbia Financial
According to the filing, the August 7, 2026 acquisition consisted of 63.1568 phantom stock units purchased on a non-discretionary basis by the trustee of the Columbia Bank rabbi trust in connection with the Columbia Bank Stock Based Deferral Plan, a non-qualified stock-based deferral plan. The filing notes that "stock unit interests under the Columbia Bank Stock Based Deferral Plan will be settled in shares of stock upon distribution to the reporting person." The per-share price was $10.84.
The filing reports Klimowich's direct holding of 145,056 shares of common stock, alongside multiple indirect positions. Indirect holdings include 67,686 shares through a 401(k), 16,779 through a SERP, 19,117 through an ESOP, and 9,269 through SIM. The filing attributes a change of 2 shares in the ESOP position and a decrease of 1 share each in the SIM and Stock Award III positions relative to prior reports, both due to rounding of fractional shares, according to the filing's footnotes.
Three stock award positions are also disclosed: 24,135 shares under Stock Award III, 25,790 under Stock Award IV, and 26,193 under Stock Award V, all granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan with performance-based vesting criteria. In addition, the filing discloses five stock option grants covering 414,117, 26,466, 19,470, 44,682, and 44,499 shares of common stock, with exercise prices of $7.10, $7.25, $7.50, $7.38, and $8.31 respectively, and expiration dates ranging from July 23, 2029, through March 2, 2036. The filing was signed by Thomas F. Splaine, Jr., acting under a power of attorney, on August 11, 2026.
What Was Disclosed
John Klimowich, SEVP and Chief Risk Officer of NASDAQ:CLBK, reported a non-discretionary phantom stock acquisition of 63.1568 shares at $10.84 on August 7, 2026, along with a full accounting of his direct and indirect beneficial ownership across multiple plans and equity awards.



Please wait processing your request...